Just a few more days until #MPS2026! Join us in Booth #321 to meet with members of our team and get hands-on with our award-winning AVA™ Emulation System. The MPS Word Summit focuses on advancing human-relevant models and shaping the future of drug development through global collaboration among research, industry, and regulatory bodies. We’re proud to be part of a community that shares progress, exchanges ideas, and contributes to the adoption, scalability, regulatory alignment, and real-world implementation of Microphysiological Systems technologies. View our full agenda of presentations and posters, or set up a meeting with our team at https://lnkd.in/dcqTchiy
Emulate, Inc.
Biotechnology Research
Boston, MA 29,379 followers
Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biology and disease.
About us
Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate’s Organ-Chip platforms, consumables, and organ models help the world’s leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies.
- Website
-
http://www.emulatebio.com
External link for Emulate, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Understanding Disease, Personalized Health, Microfluidics, Human Biology, 3D in vitro models, and Organ-on-a-Chip Technology
Locations
-
Primary
Get directions
The Innovation & Design Building
Drydock Avenue
Boston, MA 02210, US
-
Get directions
-
Get directions
27 Drydock Ave
Boston, MA 02210, US
Employees at Emulate, Inc.
Updates
-
What if you could combine the biological fidelity of in vivo models with the scale and efficiency of in vitro systems in one platform? The AVA™ Emulation System is a first-of-its-kind, fully integrated Organ-on-a-Chip workstation designed to do exactly that. With AVA, teams can: 🔹 Run up to 96 independent Organ-Chip samples in parallel, bringing microplate-level throughput to Organ-Chips 🔹 Capture real-time imaging, generating rich, multi-modal AI-ready datasets across experiments 🔹 Reduce consumable costs (up to 4x lower) and hands-on lab time (by more than half) through automation and streamlined workflows 🔹 Combine incubation, culture, and imaging in one system to eliminate the need for multiple instruments The result: a platform that allows scientists to ask bigger questions earlier and make more confident decisions faster. As the industry shifts toward human-relevant, non-animal methods, AVA provides a practical path forward, helping translate innovation into scalable, everyday use. Learn more about AVA: https://lnkd.in/gVs5SVQ9
-
-
The AVATAR program united many talented minds, collaborating across organizations, to successfully take to the stars. In this The Scientist op-ed, co-authored by our Scientific Founder, Dr. Donald Ingber, with Dr. David Chou, peek behind the curtain to better understand what drove this program from pre-lift-off to present. Together, we’re using Organ-Chips to better understand human biology in space and at home, on planet Earth. #Space #OrganOnAChip #Biology #ArtemisII
When the Orion capsule splashed back down on Earth recently, marking the successful end of the historic Artemis II mission, the world's eyes were understandably fixed on the four astronauts who bravely flew around the far side of the moon. But hidden inside a metal container beside the astronauts was a different sort of crew: a group of human bone marrow organ chips. These chips flew alongside the astronauts as part of the AVATAR project, funded by NASA - National Aeronautics and Space Administration and Biomedical Advanced Research and Development Authority (BARDA), which aims to use this technology to create personalized living avatars that simulate individual astronauts' responses to radiation and microgravity. In this op-ed I wrote with David Chou, find out why we used bone marrow chips, how we created them through a collaboration Emulate, Inc. Inc and Space Tango to build the chips and keep them alive in space, our pre-liftoff preparations, how we’re using the chips to study the impact of spaceflight on human health, and the potential impact of our findings on the future of space travel and healthcare here on Earth. https://lnkd.in/exvxJTvY
-
The MPS World Summit is just around the corner! We’re looking forward to seeing everyone in DC at booth #321, but we cannot forget what a great time the community had in Brussels last year. Check out our team and booth in the Maison de la Poste from MPS 2025. This year, we will be contributing even more to the conversation, with a full agenda of presentations and posters featuring Emulate scientists or data generated from our platforms. View them all or set up a meeting at https://lnkd.in/dcqTchiy #MPS2026 #MPSWorldSummit #OrganOnAChip #NAMs #DrugDevelopment #FlashbackFriday
-
-
Join us for an upcoming online symposium with Drug Discovery News! Our Chief Scientific Officer, Lorna Ewart, PhD, will be joining fellow industry experts to explore how emerging technologies, such as New Approach Methodologies (#NAMs) and human-relevant models, are helping to improve predictivity, streamline development, and transform #drugdiscovery. See the full lineup of speakers and register at https://lnkd.in/gsYvVpGW Image courtesy of Drug Discovery News.
-
-
Emulate, Inc. reposted this
Congratulations to the Biosensing, Microfluidics, and Microsystems team from Wyss Institute at Harvard University for winning the Lush Prize for Science 2026. A huge thank you to LUSH for honouring the team with soaps in the original chip design and for your generous hospitality. I am proud to be an alumni of this prestigious community.
-
-
A recent publication in Tissue&Cell presents a novel organ-on-a-chip model of oral dysplasia (OD-OoC), designed to better replicate the complex tissue interactions underlying precancerous lesions in the oral cavity. The microfluidic platform integrates endothelial cells, gingival fibroblasts, and dysplastic oral keratinocytes to mimic tissue interactions and early precancer changes under flow. Key findings include: 🔹 Spatial organization of multiple human cell types within a dynamic microenvironment 🔹 Fibroblast migration across the membrane, capturing key aspects of tissue remodeling 🔹 Distinct dysplastic epithelial phenotypes compared to healthy cells Studies like this highlight the potential of Organ-on-a-Chip technologies to serve as physiologically relevant in vitro tools to study early mechanisms involved in oral cancer development and other complex, multicellular diseases. The authors leveraged our pioneering Chip-S1® Stretchable Chips for their research. Read the full publication at https://lnkd.in/gmrNVg6y #OrganOnAChip #CancerResearch #DiseaseModeling #NAMs #Oncology Image courtesy of the authors at the Department of Medical, Oral and Biotechnological Sciences, University “G. d’Annunzio.
-
-
We're #hiring a new External Manufacturing Operations Manager in Boston, Massachusetts. Apply today or share this post with your network.
-
We're #hiring a new Director / Senior Director, Corporate Development in Boston, Massachusetts. Apply today or share this post with your network.
-
The conversation around human-relevant science has reached new heights—literally. Whether it was spaceflight-enabled research during the Artemis II mission, FDA milestones, or growing industry recognition, April highlighted how Organ-on-a-Chip technology continues to expand what’s possible in drug development and discovery. #NAMs #OrganOnAChip #DrugDevelopment #Organoids #FDA